ArticleAmerican journal of hematology2025

Feasibility of a Biomarker-Based Screening for Pre-Symptomatic AL Amyloidosis in Patients With Intermediate/High-Risk MGUS.

Silvia Mangiacavalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.